ProCE Banner Activity

Impact of the 2022 ADA/EASD Consensus Statement on the Management of T2D

Clinical Thought

A leading expert discusses recent guideline updates and how they have changed the treatment of type 2 diabetes.

Released: April 25, 2023

Share

Faculty

Martin J. Abrahamson

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

Disclosure

Primary Author

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine
Harvard Medical School
Director, Division of CME
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Martin J. Abrahamson, MD, FACP: consultant: WebMD.